BRNS vs EVAX
Comparison between Barinthus Biotherapeutics Plc. (BRNS, Company) and Evaxion Biotech A/S (EVAX, Company).
Both BRNS and EVAX are from the Healthcare sector.
5-Year PerformanceBRNS has outperformed EVAX, delivering a return of -47.6% compared to -59.9%
BRNS vs EVAX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
BRNS vs EVAX - Historical Returns
Returns include dividend reinvestment.
BRNS vs EVAX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | BRNS | EVAX |
|---|---|---|
| 2026 | -22.37% | -39.92% |
| 2025 | -43.54% | +3.22% |
| 2024 | -67.35% | -88.42% |
| 2023 | +53.75% | -60.59% |
| 2022 | -78.87% | -61.24% |
| 2021 | -21.21% | -55.31% |
BRNS vs EVAX Drawdown Comparison
The maximum drawdown for BRNS was -96.82%, occurring on Apr 1, 2026. This drawdown has not yet recovered.
The maximum drawdown for EVAX was -99.79%, occurring on Apr 21, 2025. This drawdown has not yet recovered.
The current BRNS drawdown is -96.64%. The current EVAX drawdown is -99.55%.
| Rank | BRNS | EVAX |
|---|---|---|
| #1 | -96.82% May 17, 2021 - Apr 1, 2026 | -99.79% Nov 4, 2021 - Apr 21, 2025 |
| #2 | -8.56% May 3, 2021 - May 12, 2021 | -47.74% Feb 8, 2021 - Nov 4, 2021 |
Correlation
Correlation between BRNS and EVAX is 0.96 which considered as a very strong positive correlation - the stocks move almost identically together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks